ClinicalTrials.Veeva

Menu

Comparison of AmblyzTM Glasses and Patching for Amblyopia

Indiana University logo

Indiana University

Status

Terminated

Conditions

Amblyopia

Treatments

Device: 2-hour patching
Device: 12-hour AmblyZ glasses
Device: 6-hour patching
Device: 4-hour AmblyZ glasses

Study type

Interventional

Funder types

Other

Identifiers

NCT01973348
1307011930

Details and patient eligibility

About

Electronic eyeglasses, Amblyz™glasses, are a new medical device designed to treat amblyopia, which intermittently become opaque and provide effective occlusion for 50% of the time they are worn. A non-randomized study reported that Amblyz glasses yield an improvement in the amblyopic eye and offer an alternative effective treatment. We are unaware of any randomized clinical trial reports of response to AmblyzTM glasses treatment of amblyopia.

Our hypothesis: Amblyz™glasses can improve visual acuity of the amblyopic eye as effective as traditional patching treatment.

The primary objective is to determine if AmblyzTM equally treats moderate amblyopia as the standard 2-hour patching treatment and AmblyzTM equally treats severe amblyopia as the standard 6-hour patching treatment.

This study is designed to evaluate the effectiveness of a novel amblyopia treatment, AmblyzTM glasses, in treating amblyopia.

Moderate amblyopia: Children ages 3 to <8 years with visual acuity of 20/40 to 20/80 in the amblyopic eye will be enrolled and randomized into two groups: 4-hour AmblyzTM glasses treatment group and standard 2-hour patching control group.

Severe amblyopia: Children ages 3 to <8 years with visual acuity of 20/100 to 20/400 in the amblyopic eye will be enrolled and randomized into two groups: 12-hour AmblyzTM glasses treatment group and standard 6-hour patching control group.

Enrollment

45 patients

Sex

All

Ages

3 to 8 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Both genders and all races are eligible to this study.
  • Age 3 to 8 years
  • Amblyopia associated with strabismus, anisometropia, or both
  • Visual acuity in the amblyopic eye between 20/40 and 20/80 inclusive
  • Visual acuity in the sound eye 20/40 or better and inter-eye acuity difference >3 logarithm of the minimum angle of resolution (logMAR) lines
  • Wearing of optimal spectacle correction for a minimum of 4 weeks at the time of enrollment.

Exclusion criteria

• No amblyopia treatment before enrollment.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

45 participants in 4 patient groups

4-hour AmblyZ glasses
Experimental group
Description:
4-hour AmblyZ glasses for moderate amblyopia
Treatment:
Device: 4-hour AmblyZ glasses
2-hour eye patching
Active Comparator group
Description:
2-hour eye patching for moderate amblyopia
Treatment:
Device: 2-hour patching
12-hour AmblyZ glasses
Experimental group
Description:
12-hour AmblyZ glasses for severe amblyopia
Treatment:
Device: 12-hour AmblyZ glasses
6-hour eye patching
Active Comparator group
Description:
6-hour eye patching for severe amblyopia
Treatment:
Device: 6-hour patching

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems